The project was a success, with the first commercial implantation of a Nucleus implant taking place in 1982. Although it was established as a subsidiary of Nucleus, which was acquired by Pacific Dunlop in 1988, Cochlear soon became a separate and publicly listed company in 1995 when Pacific Dunlop was split up.
The project's success led to the first commercial use of a Nucleus implant in 1982. Although it started as a subsidiary of Nucleus, which was acquired by Pacific Dunlop in 1988, Cochlear eventually became its own separate and publicly traded company in 1995 when Pacific Dunlop was split up.